Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Michael Okunewitch is an analyst at Maxim Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/20/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/20/2025 | CMMB | Buy Now | Chemomab Therapeutics | $1.42 | 392.96% | Michael Okunewitch25% | $4 → $7 | Maintains | Buy | Get Alert |
| 02/14/2025 | MYNZ | Buy Now | Mainz Biomed | $4.29 | 226.34% | Michael Okunewitch25% | → $14 | Initiates | → Buy | Get Alert |
| 01/10/2025 | LCTX | Buy Now | Lineage Cell Therapeutics | $0.51 | 488.24% | Michael Okunewitch25% | $5 → $3 | Maintains | Buy | Get Alert |
| 11/27/2024 | CTOR | Buy Now | Citius Oncology | $0.59 | 406.84% | Michael Okunewitch25% | → $3 | Initiates | → Buy | Get Alert |
| 10/15/2024 | OCGN | Buy Now | Ocugen | $0.54 | 640.74% | Michael Okunewitch25% | → $4 | Initiates | → Buy | Get Alert |
| 09/24/2024 | FBLG | Buy Now | FibroBiologics | $0.99 | 1108.34% | Michael Okunewitch25% | → $12 | Initiates | → Buy | Get Alert |
| 08/27/2024 | LGVN | Buy Now | Longeveron | $1.66 | 261.21% | Michael Okunewitch25% | $15 → $6 | Maintains | Buy | Get Alert |
| 05/13/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.42 | 181.69% | Michael Okunewitch25% | → $4 | Initiates | → Buy | Get Alert |
| 03/05/2024 | LEXX | Buy Now | Lexaria Bioscience | $1.47 | 716.33% | Michael Okunewitch25% | $3 → $12 | Maintains | Buy | Get Alert |
| 12/07/2023 | DMK | Buy Now | DMK Pharmaceuticals | — | — | Michael Okunewitch25% | → $1.5 | Initiates | → Buy | Get Alert |
| 10/05/2023 | ACRV | Buy Now | Acrivon Therapeutics | $5.46 | 339.56% | Michael Okunewitch25% | → $24 | Initiates | → Buy | Get Alert |
| 09/21/2023 | ANEB | Buy Now | Anebulo Pharmaceuticals | $2.00 | 199.96% | Michael Okunewitch25% | → $6 | Initiates | → Buy | Get Alert |
| 08/09/2023 | KPRX | Buy Now | Kiora Pharmaceuticals | $3.33 | -39.94% | Michael Okunewitch25% | $108 → $18 | Maintains | Buy | Get Alert |
| 07/21/2023 | LEXX | Buy Now | Lexaria Bioscience | $1.47 | 36.05% | Michael Okunewitch25% | → $2 | Initiates | → Buy | Get Alert |
| 04/12/2023 | ALZN | Buy Now | Alzamend Neuro | $1.00 | 50% | Michael Okunewitch25% | → $225 | Initiates | → Buy | Get Alert |
| 02/09/2023 | KPRX | Buy Now | Kiora Pharmaceuticals | $3.33 | 260.36% | Michael Okunewitch25% | → $108 | Upgrade | Hold → Buy | Get Alert |
| 12/22/2022 | MDWD | Buy Now | MediWound | $18.20 | 37.36% | Michael Okunewitch25% | → $25 | Initiates | → Buy | Get Alert |
| 09/28/2022 | BRTX | Buy Now | BioRestorative Therapies | $1.65 | 263.64% | Michael Okunewitch25% | → $6 | Initiates | → Buy | Get Alert |
| 08/15/2022 | KPRX | Buy Now | Kiora Pharmaceuticals | $3.33 | — | Michael Okunewitch25% | — | Downgrade | Buy → Hold | Get Alert |
| 03/24/2022 | HCWB | Buy Now | HCW Biologics | $0.30 | 1214.06% | Michael Okunewitch25% | → $4 | Initiates | → Buy | Get Alert |
| 03/24/2022 | LGVN | Buy Now | Longeveron | $1.66 | 742.82% | Michael Okunewitch25% | → $140 | Initiates | → Buy | Get Alert |
| 02/09/2022 | SQL | Buy Now | SeqLL | — | — | Michael Okunewitch25% | → $120 | Initiates | → Buy | Get Alert |
| 11/30/2021 | ATAI | Buy Now | ATAI Life Sciences | $1.42 | 1660.56% | Michael Okunewitch25% | → $25 | Initiates | → Buy | Get Alert |
| 11/30/2021 | CTXR | Buy Now | Citius Pharma | $1.68 | 138.36% | Michael Okunewitch25% | → $100 | Initiates | → Buy | Get Alert |
